Skip to content
Delayed ~15 min

MRK Merck & Co.

Health Care · S&P 500 · Dow Jones

Next earnings: not announced yet

What 32 analyst firms say about Merck & Co: their latest ratings, price targets and how far the stock is from them. How it works

146.73 USD−0.21 (−0.14%) today
Price as of 6 Nov 16:03 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+7.3%to the avg target 157.48 USD+10.75 USD
Buy 22 · Hold 8 · Sell 1

31 rated views · 32 analyst/firm records · 32 firms

Latest report30 Oct 2026avg report date 2 Sep
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • S&P 500 · Top Picks · 6MBelow the Radar threshold of 8043
  • S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8052
Other indices (1)
  • Dow Jones · Top Picks · 6MBelow the Radar threshold of 8033
  • Dow Jones · Safest consensus · 6MBelow the Radar threshold of 8038

Recent analyst activity · last 90 days

Our tracked history has 40 reports on MRK from 27 analyst firms in the last 90 days (32 firms in the past year).

Comparing each firm's latest target with its previous one: 11 raised their price target, 3 lowered it, 5 left it unchanged and 4 have their first observed target in the past year.

Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.

Latest observed target change: Cantor Fitzgerald raised its target from $145.00 (set 8 Oct 2026) to $155.00 on 2 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
ArgusJasper HellwegBuy25 Aug 2026170.00 USD
Bank of America SecuritiesTim AndersonBuy30 Jun 2026141.00 USD
BarclaysEmily FieldBuy26 Oct 2026180.00 USD
BerenbergLuisa HectorHold10 Jul 2026137.00 USD
BernsteinCourtney BreenHold26 Oct 2026105.00 USD
BMO Capital MarketsEvan David SeigermanBuy20 Aug 2026170.00 USD
Cantor FitzgeraldCarter GouldHold8 Oct 2026145.00 USD
CICCUnnamed analystBuy24 Jun 2026138.00 USD
CitigroupGeoff MeachamHold12 Oct 2026145.00 USD
DaiwaNarumi NakagiriBuy12 Aug 2026143.00 USD
DBSNico ChenBuy11 Sep 2026180.00 USD
Deutsche BankJames ShinBuy13 Feb 2026150.00 USD
DZ BankElmar KrausBuy5 Aug 2026156.00 USD
Erste GroupHans EngelHold18 Sep 2026—
Evercore ISIUmer RaffatBuy1 Jul 2026—
Freedom Capital MarketsIlya ZubkovHold23 Jul 2026125.00 USD
Goldman SachsAsad HaiderBuy16 Oct 2026Conflicting reports · excluded
GuggenheimVamil DivanBuy30 Oct 2026171.00 USD
HSBCRajesh KumarBuy10 Sep 2026Conflicting reports · excluded
JefferiesAkash TewariBuy19 Aug 2026Conflicting reports · excluded
JPMorganChris SchottBuy30 Oct 2026175.00 USD
Leerink PartnersDaina GrayboschBuy9 Sep 2026161.00 USD
Morgan StanleyTerence FlynnBuy7 Oct 2026177.00 USD
RBC Capital MarketsTrung HuynhHold30 Oct 2026140.00 USD
RedburnSteven K ChesneyBuy8 Oct 2026173.00 USD
ScotiabankLouise ChenBuy29 Sep 2026180.00 USD
TD CowenSteve M ScalaHold23 Sep 2026155.00 USD
UBSMichael YeeBuy20 Aug 2026175.00 USD
Weiss RatingsUnnamed analyst—25 Aug 2026—
Wells FargoMohit BansalBuy9 Oct 2026165.00 USD
Wolfe ResearchAlexandria HammondBuy25 Aug 2026180.00 USD
Data feed RESEARCHResearch TeamSell19 Oct 2026Conflicting reports · excluded

Partial coverage · checked 6 Nov (6 Nov 2026, 03:58 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.